Multiples studies indicate that chronic increases in heart rate are associated with changes in the waveform of the action potential (AP) of atrial and ventricular myocytes. In atria, sustained, high-frequency electric activation rates are associated with shortening of the AP of atrial myocytes. 4, 5 This results in a decrease in the refractory period of the AP of atrial myocytes, which could increase the probability of atrial fibrillation, the most common cardiac arrhythmia. Interestingly, a decrease in depolarizing L-type Ca 2ϩ channel current (I Ca ) function has been linked to decreased atrial AP duration during tachycardia. 6, 7 Downregulation of the transcript and protein levels of the pore-forming ␣ subunit of L-type Ca 2ϩ channels (Cav1.2) underlie decreased I Ca function during atrial tachycardia and fibrillation.
Like atrial myocytes, long-term tachycardia could also alter the waveform of the AP of ventricular myocytes and has been found to cause heart failure in canine. 8 Chronic tachycardia decreases the amplitude of the transient outward K ϩ current (I to ), which alters phase 1 of the ventricular AP. This has the potential of altering excitation-contraction coupling 9,10 and increasing arrhythmogenesis 11 during heart failure.
Rate-dependent decreases in I to are caused, at least in part, by downregulation of transcript and protein levels of Kv4.3 12 channel subunits in human and canine ventricular myocytes.
As noted above, Xiao et al 1 13 Second, there are putative NFAT-binding sites in the promoter region of Cav1.2 and Kv4.3 genes. 14, 15 Third, activation of NFATc3 downregulates I to in mouse ventricular myocytes. 14, 15 On the basis of these findings, Xiao et al 1 and Qi et al 2 hypothesized that rate-dependent changes in [Ca 2ϩ ] i , as well as the activity of the Ca 2ϩ -dependent phosphatase calcineurin and the transcription factor NFATc3, could form part of a signaling cascade that downregulates Cav1.2 and Kv4.3 expression in atrial and ventricular myocytes during tachycardia.
Step 2: Devising a Plan
To test their hypothesis, Xiao et al 1 and Qi et al 2 implemented a multidisciplinary, integrative approach. They used an in vitro (ie, cell culture) approach to submit atrial and ventricular myocytes to vary stimulation rates (0, 1, or 3 Hz) for 24 hours. Experiments involved the recording of [Ca 2ϩ ] i , APs, I Ca , and I to and measurements of calcineurin activity and NFAT translocation in atrial and ventricular myocytes. Pharmacological tools were used to determine the role of Ca 2ϩ /calmodulin-dependent kinase (CaMK)II, calcineurin, NFATc3, and NFATc4 in Cav1.2 and Kv4.3 downregulation.
Step 3: Carrying Out the Plan
Using these approaches, Xiao et al 1 and Qi et al 2 elegantly demonstrated that increasing the AP firing rate from 0 to 1 to 3 Hz increased [Ca 2ϩ ] i , thereby activating calcineurin. In ventricular myocytes, but not atrial myocytes, calcineurin is activated through a CaMKII-dependent mechanism. Activation of calcineurin dephosphorylates NFATc3 and NFATc4, which allows these transcription factors to translocate into the nuclei of atrial (NFATc3 and NFATc4) and ventricular myocytes (NFATc3 only), in which they can modulate the expression of Cav1.2 (atrial myocytes) and the Kv4.3 (ventricular myocytes) genes. The data supporting this model are compelling. (1) Increasing AP firing rates from 0 to 1 to 3 Hz downregulated I Ca and I to function and Cav1.2 and Kv4.3 transcripts and proteins in atrial and ventricular myocytes. (2) It also increased diastolic and systolic [Ca 2ϩ ] i in these cells, and
(3) calcineurin activity was higher in cells stimulated at 3 Hz than at 1 Hz. In ventricular myocytes, but not atrial myocytes, rate-dependent changes in calcineurin activity required CaMKII function. (4) Finally, increases in AP frequency augmented NFATc3 (ventricular and atrial) and NFATc4 (atrial) translocation in atrial and ventricular myocytes.
Step 4: Looking Back, Examination of the Results Obtained
The findings of Xiao et al 1 and Qi et al 2 are important because they establish, for the first time, a well-defined signaling pathway for the rate-dependent regulation of Cav1.2 and Kv4.3 expression in atrial and ventricular myocytes. However, the importance of these findings goes beyond these particular experimental conditions. Note that previous studies suggested a causal relationship between calcineurin/NFAT signal activation and the expression of specific voltage-gated ion channels in mouse ventricular myocytes. 14, 15 Yet, the role of this signaling pathway is not limited to cardiac myocytes. In smooth muscle, NFATc3 activation decreased expression of Kv2.1 15, 16 and the ␤ 1 subunit of large conductance Ca 2ϩactivated K ϩ channels 17 during the development of hypertension. Together with the work of Xiao et al 1 and Qi et al 2 in canine atrial and ventricular myocytes, these studies support the provocative hypothesis that activation of NFATc3 may be a general mechanistic point of convergence among stimuli that regulate expression of voltage-gated ion channels in the cardiovascular system. As with any good study, the impact of the work Xiao et al 1 and Qi et al 2 is not limited to the questions they answered, but the questions they raised. For example, whereas Xiao et al, 1 as well as others, 14, 15 have linked NFAT activation to downregulation of Kv4.3 in adult ventricular myocytes, a recent study suggests that NFAT could upregulate Kv4 channels in neonatal ventricular myocytes. 18 How could these seemingly contradictory findings be reconciled? One possibility is that NFAT associates with other transcription factors and binding partners, and whether NFAT upregulate or downregulate the expression of specific genes would depend on the molecular identity of the proteins this transcription factor associates with. Another question brought up by the work of Qi et al 2 is why does NFATc3/c4 activation decreases Cav1.2 in atrial but not in ventricular myocytes? Future studies should address these important issues.
In addition to inducing Kv4.3 and Cav1.2 channel downregulation, activation of calcineurin/NFAT signaling causes hypertrophy. 19 Inhibition of calcineurin decreases ventricular hypertrophy by up to 40% after myocardial infarction. 20, 21 In contrast, Xiao et al 1 and Qi et al 2 suggest that preventing calcineurin and NFAT activation completely prevents rate-dependent I to and I Ca remodeling. Given that calcineurin/NFAT inhibition only partially blocks the development of hypertrophy, whereas I to and I Ca downregulation is completely prevented, it is intriguing to speculate that there may be less redundancy in the pathways leading to Kv4.3 and Cav1.2 downregulation in atrial and ventricular myocytes.
Let us end by highlighting a central tenet in the problemsolving approach of Polya: that analyzing how others solved a particular problem could help answering new questions in the future. With this in mind, the work by Xiao et al 1 and Qi et al 2 forms part of the emerging field of excitationtranscription coupling. 22 The approaches and concepts developed by Xiao et al 1 and Qi et al 2 represent an important contribution to this field and, if one is to follow the advice of Polya, should help to unravel and clearly define signaling pathways responsible for the regulation of the expression and function of voltage-gated ion channels in excitable cells under physiological and pathophysiological conditions.
Sources of Funding
Supported by NIH grant HL085686. L.F.S. is an Established Investigator of the American Heart Association.
Disclosures
None.
